the retrovirus lav/htlv iii , highly likely to be responsible for the acquired immunodeficiency syndrome ( aids ) in some recipients of blood products , can be inactivated by chemical and/or heat treatment , so the use of virus-inactivated factor viii and factor ix preparations for treating hemophilia a and b has become important .
C0015506
factor viii
C0019069
hemophilia a